policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
National Animal Health Laboratory Network (NAHLN) funding
The AVMA advocates for funding to develop and maintain infrastructure for a comprehensive National Animal Health Laboratory Network so that the U.S.…
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…